We're thrilled to announce that Sanobiotec, a pioneering name in cannabinoid wellness, will be a prominent participant at the upcoming White Label World Expo Frankfurt.... read more →
In recent years, the world of cannabinoids has expanded beyond the confines of the familiar cannabis plant. Scientists have been delving into the intriguing realm of non-cannabis plants... read more →
In a poignant and reflective moment that reverberates throughout the global scientific community, we come together to mourn the passing of Dr. Raphael Mechoulam, a visionary whose pioneering research... read more →
Some say that cannabinoids are miracle molecules, but there are certain pitfalls that come with anything entitled as miracle. As we are all working in the cannabis industry we know a lot and here we are not talking about the chemistry. ... read more →
Body is a rather complex biological mechanism that has many systems working without us even noticing. Regulation of blood-flow, reflex system, sugar uptake and release, hormonal regulation...... read more →
Hemp industry currently is at an all time high (capital-wise) with booming CBG, THC and CBD products' branches. What is more, CBN, which is currently undergoing clinical trials for insomnia in Australia [1], is steadily stepping on it's own as a new wave of cannabinoid products.... read more →
There are many ways and many sources of raw materials for making a product. Some brands get glorified by the repeatedly excellent quality of their products, whereas other brands are notoriously untrustworthy. The recipe for a successful brand is based on many things: great marketing, attractive packaging, rapid delivery, competing price, naturally sourced ingredients, good manufacturing practices and trustworthy analysis of both raw ingredients and final goods. And third-party testing is probably the most important factor in deciding if the final product is ready to hit the market! So what is it and why is it necessary?... read more →
Cannabidiol is one of the many cannabinoids found in hemp plant. Even though some articles claim that there is well over 100 of cannabinoids, CBD is one of the best described ones. Decades of research have revealed it's potential benefits, side effects, uses and even allowed pharmaceutical companies to develop medicinal treatments based on this molecule. So let's dive and explore this interesting compound!... read more →
There’s a lot of debate nowadays about the natural vs synthetic origins of minor cannabiniods. Naturally, various strains of cannabis plant produce ample amounts of THC, CBD and CBG. Whereas minor cannabinoids are trickier – there can be anywhere from 1% to untraceable amounts of them. ... read more →
Hemp is a multipotent plant that comes in handy anywhere from building (hempcrete) to textiles (hemp fabric) to medicine (THC in dronabinol and CBD in epidiolex). Cannabis plant contains plethora of various cannabinoids: THC, CBD, CBN, CBG, CBC and others. What is the difference between CBD, CBG and CBN? These three plus THC are major cannabinoids found in hemp.... read more →
CBD and CBG might sound like fun new acronyms, but they're actually two of the many chemical compounds found in cannabis plants. While both offer potential benefits, there are a few key differences between them.... read more →
If you missed the Cosmetic Ingredients Trade Show 2022 | In-Cosmetics Global in Paris, we at Sanobiotec are here to let you in on fascinating topics and trends regarding cannabinoids and their perspectives in the cosmetics industry which we gleaned in the fair. ... read more →
Tomas Kunstmonas, Head of Development at Sanobiotec, discusses the perspectives of rare cannabinoids, chemical synthesis advantages, and many other questions related to minor cannabinoids.... read more →
The new policy has been adopted in Europe that will allow a maximum THC level on the field of 0.3%. This will enter into force on January 1st, 2023.... read more →
On November 3, Rytis V. Urbonas, co-founder of Sanobiotec, participated in a trade mission in Basel, Switzerland on Life sciences partnership opportunities: Innovative ecosystem co-creation with Lithuanian leaders. ... read more →
On September 24th, the Minister of the Economy and Innovation of the Republic of Lithuania, Aušrinė Armonaitė together with her team visited Sanobiotec. The meeting took place at Sanobiotec laboratory and HQ in Vilnius, Lithuania. ... read more →
Sanobiotec will participate in this year’s WHITE LABEL WORLD EXPO EUROPE, the international trade fair for thousands of the world's top suppliers, held on October 13-14 at the Messe Frankfurt, Germany. ... read more →
The updated site gives you more insights on minor cannabinoids and why we believe that these compounds have the potential to create value for our partners and the power to positively affect the lives of countless people around the world. ... read more →
FAST-growing Lithuanian business Sanobiotec aims to be a leading global player delivering on the potential of the many ‘minor’ cannabinoids, as Co-Founder Rytis Vincentas Urbonas explains.... read more →
Sanobiotec continues to push the limits of minor cannabinoid manufacturing technology, effectiveness, and compliance. In-house quality control and strict adherence to the highest manufacturing standards are crucial to the success and integrity of the entire cannabinoid industry.... read more →
Therapeutic use of cannabis is a growing industry increasingly accepted by the medical community and general public — but that growth may be stopped if biopharma companies lack reliable methods to extract and purify potentially useful compounds from the plant. ... read more →
Professor Edvinas Orentas, Department of Organic Chemistry, Vilnius University, Lithuania and Head of Research at Sanobiotec, discusses the stigma of synthetic cannabinoids in the Cannabis Science and Technology interview by Madeline Colli. Interview originally was published here.... read more →
Sanobiotec Refines Production of CBC: Non-psychoactive Cannabinoid with Unique Therapeutic Potential
Non-psychoactive components of Cannabis Sativa continue to make inroads in medicine with numerous studies demonstrating their comprehensive therapeutic potential.... read more →
EIHA projects GmbH, together with ChemSafe, their scientific provider, announced that they have submitted Novel Foods applications for natural CBD isolate and Full Spectrum; fully meeting the Food Safety Authority (FSA) deadline.... read more →
Synthetic cannabinoids are often regarded as a lower-quality alternative, but often they surpass natural compounds in terms of product quality and purity, Professor Edvinas Orentas, head of research at Sanobiotec, argues here. ... read more →
Positive regulatory developments are aiding the growth of the cannabis pharmaceuticals market, but more clinical data are needed to break the stigma and bring science to the fore.... read more →
Out of more than a hundred cannabinoids that have so far been identified in the cannabis sativa plant, the non-intoxicating cannabidivarin (CBDV)... read more →
It is hoped that the pure ingredient will open up new research prospects for pharma, wellness industry, and other market players.
... read more →
The question of how to achieve greater bioavailability of cannabinoids has been one of the main challenges for researchers in the cannabis industry, and for a good reason.... read more →
If you check out the biotechnology sector overview on Go Vilnius website, you might notice a familiar name – #Sanobiotec among fellow biotech companies operating from Vilnius. ... read more →
Sanobiotec aims to improve the technological processes for production of these compounds and leverage their therapeutic benefits for pharmaceuticals, wellness industry and treatment of progressive illnesses, such as cancer or Alzheimer’s.... read more →
The cannabinoids THC and CBD are the most prominent compounds in the cannabis industry and are well-known for their health benefits.... read more →
For 2020, the BIO International Convention will transition to a new, virtual event format, BIO Digital. This virtual gathering of the global biotech industry provides access... read more →